This blog post serves to simplify these scholarly papers: Indications, Techniques, and Outcomes of Bridge-Enhanced ACL Restoration , published in PubMed. A Preliminary Study of Post-Market Bridge-Enhanced ACL Restoration (BEAR) Suggests Non-Inferior Short-Term Outcomes and Low Complications , published in PubMed. Two-Year Results in Bridge-Enhanced ACL Repair Feasibility Study , published by Miach Orthopaedics. University Orthopedics Part of BEAR-MOON Clinical Trial- A Federa

This blog post serves to simplify these scholarly papers: Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial , published in the Nature Medicine Journal by Isabel Deisenhofer and TAILORED-AF Investigators. Atrial Fibrillation , published in the National Center for Biotechnology Information (NCBI) by Zeid Nesheiwat and associates. What is Atrial Fibrillation (AF)? Atrial Fibrillation is one of the most commo

This blog post simplifies and expands on an article posted by Scripps Research. It explores parts of this research paper. A Brain Organoid is a scaled down version of a real brain, only composed of one million or so cells. It reflects the inter-cell relationships and communication that regular sized brains also exhibit. Think of Brain Organoids as a model brain that we can ethically experiment on.  This is a six-well plate of Brain Organoids grown from stem cells. Picture ta

This blog post simplifies an article posted by the Yale School of Medicine, and explores the technologies mentioned in the article. Earlier this year in February a clinical trial was led by David Braun, MD, PhD, to explore the usage of Personalized Cancer Vaccines (PCVs) in patients with advanced kidney cancer. Let’s explore what PCVs are and how they work: What is a Personalized Cancer Vaccine? Rather than being a vaccine used for prevention, this is a therapeutic vaccine,